Methylprednisolone Completed Phase 3 Trials for Dry Eye Syndrome (DES) / Ophthalmopathy, Thyroid-Associated Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01579539The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy